Overview of glucose signaling in mesangial cells in diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 14, Issue 5, 2003, Pages 1374-1382

  Haneda, Masakazu ^a   Koya, Daisuke ^a   Isono, Motohide ^a   Kikkawa, Ryuichi ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; MITOGEN ACTIVATED PROTEIN KINASE; POLYOL; PROTEIN KINASE C; RUBOXISTAURIN; TRANSFORMING GROWTH FACTOR BETA1;

DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HUMAN; MESANGIUM CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0037408533     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000064500.89551.76     Document Type: Review

References (111)

1. DCCT: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetesmellitus. N Engl J Med 329: 977-986, 1993
2. UKPDS: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352: 837-853, 1998
3. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus-a randomised prospective 6-year study. Diabetes Res Clin Pract 28: 103-117, 1995
4. Fioretto P, Steffes MW, Sutherland DE, Goetz FC, Mauer M: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 339: 69-75, 1998
5. Steffes MW, Osterby R, Chavers B, Mauer SM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38: 1077-1081, 1989
6. Mogensen CE: Glomerular filtration rate and renal plasma flow in short term and long term juvenile diabetes mellitus. Scand J Clin Invest 28: 91-100, 1971
7. Hostetter TH, Troy JL, Brenner BM: Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 19: 410-415, 1981
8. Haralson MA: Collagen polymorphism in cultured rat kidney mesangial cells. Lab Invest 57: 513-523, 1987
9. Ardaillou N, Bellon G, Nivez M-P, Rakotoarison S, Ardaillou R: Quantification of collagen synthesis by cultured human glomerular cells. Biochem Biophys Res Comm 991: 445-452, 1989
10. Ausiello DA, Kreisberg JI, Roy C, Karnovsky MJ: Contraction of cultured rat glomerular cells of apparent mesangial origin after stimulation with angiotensin II and vasopression. J Clin Invest 65:754-760, 1980
11. Blantz RC, Konnen KS, Tucker BJ: Angiotensin II effects upon the glomerular microcirculation and ultrafiltration coefficient of the rat. J Clin Invest 57: 419-434, 1976
12. Ayo SH, Radnik RA, Garoni JA, Glass II WF, Kreisberg JI: High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells. Am J Pathol 136: 1339-1348, 1990
13. Ayo SH, Radnik RA, Glass WFd, Garoni JA, Rampt ER, Appling DR, Kreisberg JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260: F185-F191, 1991
14. Haneda M, Kikkawa R, Horide N, Togawa M, Koya D, Kajiwara N, Ooshima A, Shigeta Y: Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells. Diabetologia 34: 198-200, 1991
15. Kikkawa R, Kitamura E, Fujiwara Y, Arimura T, Haneda M, Y. S: Impaired contractile responsiveness of diabetic glomeruli to angiotensin II: A possible indication of mesangial dysfunction in diabetes mellitus. Biochem Biophys Res Commun 136: 1185-1190, 1986
16. Mene P, Pugliese G, Pricci F, DiMario U, Cinotti GA, Pugliese F: High glucose inhibits cytosolic calcium signaling in cultured rat mesangial cells. Kidney Int 43: 585-591, 1993
17. Haneda M, Kikkawa R, Koya D, Uzu T, Maeda S, Togawa M, Shigeta Y: Alteration of mesangial response to ANP and angiotensin II by glucose. Kidney Int 44: 518-526, 1993
18. Schambelan M, Blake S, Sraer J, al e: Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest 75: 404-412, 1985
19. Craven PA, Patterson MC, DeRubertis FR: Role of enhanced arachionate availability through phospholipase A2 pathway in mediation of increased prostaglandin synthesis by glomeruli from diabetic rats. Diabetes 37: 429-435, 1988
20. Williams B, Schrier RW: Glucose-induced protein kinase C activity regulated arachidonic acid release and eicosanoid production by cultured glomerular mesangial cells. J Clin Invest 92: 2889-2896, 1993
21. Wakisaka M, He Q, Spiro MJ, Spiro RJ: Glucose entry into rat mesangial cells is mediated by both Na+-coupled and facilitative transporters. Diabetologia 38: 291-297, 1995
22. Heilig CW, Liu Y, England RL, Freytag SO, Gilbert JD, Heilig KO, Zhu M, Concepcion LA, Brosius FCI: D-glucose stimulates mesangial cell GLUT1 expression and basal and IGF-1-sensitive glucose uptake in rat mesangial cells: Implications for diabetic nephropathy. Diabetes 46: 1030-1039, 1997
23. Heilig CW, Concepcion LA, Riser BL, Riser BL, Freytag SO, Zhu M, Cortes P: Overexpression of glucose transporters in rat mesangial cells cultured in a normal glucose milieu mimics the diabetic phenotype. J Clin Invest 96: 1802-1814, 1995
24. Ewen ME, Sluss HK, Whitehouse LL, Livingstone DM: TGF-β inhibition of Cdk4 synthesis is linked to cell cycle arrest: Cell 74: 1009-1020, 1993
25. Weigert C, Brodbeck K, Brocius III FC, Huber M, Lehmann R, Friess U, Facchin S, Aulwurm S, Haring HU, Schleicher ED, Heilig CW: Evidence for a novel TGF-b1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters. Diabetes 52: 527-535, 2003
26. Heilig CW, Kreisberg JI, Freytag S, Murakami T, Ebina Y, Guo L, Heilig K, Loberg R, Qu X, Henry D, Brosius FCI: Antisense GLUT-1 protects mesangial cells from glucose induction of GLUT-1 and fibronectin expression. Am J Physiol 280: F657-F666, 2001
27. Inoki K, Haneda M, Maeda S, Koya D, Kikkawa R: TGF-b1 stimulates glucose uptake by enhancing GLUT1 expression in mesangial cells. Kidney Int 55: 1704-1712, 1999
28. Kikkawa R, Umemura K, Haneda M, Kajiwara N, Maeda S, Nishimura C, Shigeta, Y: Identification and characterization of aldose reductase in cultured rat mesangial cells. Diabetes 41: 1165-1171, 1992
29. Kikkawa R, Umemura K, Haneda M, Ari T, Ebata K, Shigeta Y: Evidence for existence of polyol pathway in cultured rat mesangial cells. Diabetes 40: 465-471, 1987
30. Bank N, Moywer P, Aynedjian HS, Wikes BM, Silverman S: Sorbinil prevents glomerular hyperperfusion in diabetic rats. Am J Physiol 256: F1000-F1006, 1989
31. Tilton RG, Chang K, Pugliese G, Eades DM, Province MA, Sherman WR, Kilo C, Williamson JR: Prevention of hemodynamic and vasucular albumin filtration changes in diabetic rats by aldose reductase inhibitors. Diabetes 37: 1258-1270, 1989
32. Goldfarb S, Ziyadeh FN, Kem EFO, Simmons DA: Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats. Diabetes 40: 465-471, 1991
33. Passariello N, Sepe J, Marrazzo G, Cicco AD, Peluso A, Pisano MCA, Sgambato S, Tesauro P, D'Onofrio F: Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy. Diabetes Care 16: 789-795, 1993
34. Mauer SM, Steffes MW, Azar S, Brown DM: Effects of sorbinil on glomerular structure and function in long-term diabetic rats. Diabetes 38: 839-846, 1989
35. Itagaki I, Shimizu K, Kamanaka Y, Ebata K, Kikkawa R, Haneda M, Shigeta Y: The effect of an aldose reductase inhibitor (Enalrestat) on diabetic nephropathy in rats. Diabetes Res Clin Pract 25:147-154, 1994
36. Daniels B, Hostetter T: Aldose reductase inhibition and glomerular abnormalities in diabetic rats. Diabetes 38: 981-986, 1989
37. Komer A, Celsi G, Eklof A-C, Linne T, Persson B, Aperia A: Sorbinil does not prevent hyperfiltration, elevated ultrafiltration pressure and albuminuria in streptzotocin-diabetic rats. Diabetologia 35: 414-614, 1992
38. Yamaoka T, Nishimura C, Yamashita K, Itakura M, Yamada T, Fujimoto J, Kokai Y: Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA. Diabetologia 38: 255-261, 1995
39. Ng DP, Hardy CL, Burns WC, Muggli EE, Kerr N, McCausland J, Alcom D, Adams TE, Zajac JD, Larkins RG, Dunlop ME: Prevention of diabetes-induced albuminuria in transgenic rats overexpressing human aldose reductase. Endocrine 2002: 47-56, 2002
40. Nishizuka Y: Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614, 1992
41. Lynch JJ, Ferro TJ, Blumenstock FA, Brockenauer AM, Malik AM: Increased endothelial albumin permeability mediated by protein kinase C activation. J Clin Invest 85: 1991-1998, 1990
42. Rasmussen H, Forder J, Kojima I, Scriabine A: TPA-induced contraction of isolated rabbit vascular smooth muscle. Biochem Biophys Res Comm 122: 776-784, 1984
43. Kariya K, Kawahara Y, Tsuda T, Fukuzaki H, Takai Y: Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vasucular smooth muscle cells. Atherosclerosis 63: 251-255, 1987
44. Huhtala P LTC, Tryggvason K: Structure of the human type IV collagen gene. J Bio Chem 265: 11077-11082, 1990
45. Hachiya HL, Takayama S, White MF, King GL: Regulation of insulin receptor internalization in vascular endothelial cells by insulin and phorbol esters. J Biol Chem 262: 6417-6424, 1987
46. Presta M, Marier JAM, Ragnotti G: The mitogenic signaling pathway but not plasminogen activator inducing pathway of basic fibroblast growth factor is mediated through protein kinase C in fetal bovine aortic endothelial cells. J Biol Chem 109: 1877-1884, 1989
47. Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL: Preferential elevation of protein kinase C isoform βII and diacylglycerol levels in the aorta and heart of diabetic rats: Differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 89: 11059-11063, 1992
48. Shiba T, Inoguchi T, Sportsman JR, Heath W, Bursell S, King GL: Correlation of diacylglycerol and protein kinase C activity in rat retina to retinal circulation. Am J Physiol 265: E783-E793, 1993
49. Craven PA, DeRubertis FR: Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. J Clin Invest 83: 1667-1675, 1989
50. Xia P, Inoguchi T, Kem TS, Engerman RL, Oates PJ, King GL: Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia. Diabetes 43: 1122-1129, 1994
51. Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261: F571-F577, 1991
52. Kapor-Drezgic J, Zhou X, Babazono T, Dlugosz JA, Hohman T, Whiteside CI: Effect of high glucose on mesangial cell protein kinase C-delta and -epsilon is polyol pathway-dependent. J Am Soc Nephrol 10: 1193-1203, 1999
53. Ramana KV, Friedrich B, Bhatnagar A, Srivastava SK: Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-alpha in human lens epithelial cells. FASEB J 17: 315-317, 2003
54. Whiteside CI, Dlugosz JA: Mesamgial cell protein kinase C isozyme activation in the diabetic milieu. Am J Physiol 282: F975-F980, 2002
55. Kim YS, Kim BC, Song CY, Hong HK, Moon KC, Lee HS: Advanced glycation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta. J Lab Clin Med 138: 59-68, 2001
56. Chen S, Cohen MP, Lautenslager GT, Shearman CW, Ziyadeh FN: Glycated albumin stimulate TGF-beta 1 production and protein kinase C activity in glomerular endothelial cells. Kidney Int 59: 673-681, 2001
57. Ha H, Yu MR, Choi YJ, Kitamura M, Lee HB: Role of high glucose-induced nuclear factor-kappa B activation in monocyte chemoattractant protein-1 expression by mesangial cells. J Am Soc Nephrol 13: 894-902, 2002
58. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H: High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945, 2000
59. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL: Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-β, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100: 115-126, 1997
60. Babazono T, Kapor-Drezgic J, Dlugosz JA, Whiteside C: Altered expression and subcellular localization of diacylglycerol-sensitive protein kinase C isoforms in diabetic rat glomerular cells. Diabetes 47: 668-676, 1998
61. Kikkawa R, Haneda M, Uzu T, Koya D, Sugimoto T, Shigeta Y: Translocation of protein kinase C α and ζ in rat glomerular mesangial cells cultured under high glucose conditions. Diabetologia 37: 838-841, 1994
62. Lin S, Sahai A, Chugh SC, Pan X, Wallner EI, Danesh FR, Lomasney JW, Kanwar YS: High glucose stimulates synthesis of ficronectin via a novel protein kinase C, Raplb, and B-Raf signaling pathway. J Biol Chem 277: 41725-41735, 2002
63. Fumo P, Kuncio GS, Ziyadeh FN: PKC and high glucose stimulate collagen alpha1(IV) transcriptional activity in a reporter mesangial cell line. Am J Physiol 267: F632-F638, 1994
64. Studer RK, Craven PA, DeRubertis FR: Role for protein kinase C in the mediation of increased fibronectin accumulation by mesangial cells grown in high glucose medium. Diabetes 42: 118-126, 1993
65. Kreisberg J, Radnik R, Ayo S, Garoni J, Saikumar P: High glucose elevates c-fos and c-jun transcripts and protein in mesangial cell culture. Kidney Int 46: 105-112, 1994
66. Shankland SJ, Scholey JW: Expression of growth-related protooncogenes during diabetic renal hypertrophy. Kidney Int 47: 782-788, 1995
67. Weigert C, Sauer U, Brodbeck K, Pfeiffer A, Haring HU, Schleicher ED: AP-1 protein mediate hyperglycemia-induced activation of the human TGF-β1 promoter in mesangial cells. J Am Soc Nephol 11: 2007-2016, 2000
68. Borkemeyer D, Sorokin A, Dunn MJ: Multiple intracellular MAP kinase signaling cascade. Kidney Int 49: 1187-1198, 1996
69. Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, Kikkawa R: Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 46: 847-853, 1997
70. Awazu M, Ishikura K, Hida M, Hoshiya M: Mechanisms of mitogen-activated protein kinase activation in experimental diabetes. J Am Soc Nephrol 10: 738-745, 1999
71. Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang ZY, Yamauchi T, Kuboki K, Meier M, Rhodes CJ, King GL: Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 103: 185-195, 1999
72. Kang SW, Adler SG, Lapage J, Natarajan R: p38 MAPK and MAPK kinase 3/6 mRNA and activities are increased in early diabetic glomeruli: Kidney Int 60: 543-552, 2001
73. Wilmer WA, Dixon CL, Herbert C: Chronic exposure of human mesangial cells to high glucose environments activates the p38 MAPK pathway. Kidney Int 60: 858-871, 2001
74. Tsiani E, Lekas P, Fantus IG, Dlugosz J, Whiteside C: High glucose-enhanced activation of mesangial cell p38 MAPK by ET-1, ANG II, and platelet-derived growth factor. Am J Phisiol Endocrinol Metab 282: E161-E169, 2002
75. Feliers D, Duraisamy S, Faulkner JL, Duch J, Lee AV, Abboud HE, Choundhury GG, Kasinath BS: Activation of renal signaling pathways in db/db mice with type 2 diabetes. Kidney Int 60: 495-504, 2001
76. Lin L-L, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ: cPLA2 is phosphorylated and activated by MAP kinase. Cell 72: 269-278, 1993
77. Isono M, Iglesias-de la Cruz MC, Chen S, Hong SW, Ziyadeh FN: Extracellular signal-regulated kinase mediates stimulation of TGF-β1 and matrix by high glucose in mesangial cells. J Am Soc Nephrol 11: 2222-2230, 2000
78. Goruppi S, Bonventre JV, Kriakis M: Signaling pathways and late-onset gene induction associated with renal mesangial cell hypertrophy. EMBO J 21: 5427-5436, 2002
79. Koya D, Lee I-K, Ishii H, Kanoh H, King GL: Prevention of glomerular dysfunctions in diabetic rats by treatment of d-α-tocopherol. J Am Soc Nephrol 8: 426-435, 1997
80. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R: Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14: 439-447, 2000
81. Kelly DJ, Zhang Y, Hepper C, Gow RM, Jaworski K, Kemp BE, Wilkinson-Berka JL, Gilbert RE: Protein kinase C β inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension. Diabetes 52: 512-518, 2003
82. Schleicher ED, Weigert C: Role of hexosamine biosynthetic pathway in diabetic nephropathy. Kidney Int 58[Suppl]: S13-S18, 2000
83. Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED: High glucose-induced transforming growth factor betal production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 101: 160-169, 1998
84. Kolm-Litty V, Tippmer S, Haring HU, Schleicher E: Glucosamine induces translocation of protein kinase C isozymes in mesangial cells. Exp Clin Endocrinol Diabetes 106: 377-383, 1998
85. Goldberg HJ, Whiteside CI, Fantus IG: The hexosamine pathway regulates the plasminogen activator inhibitor-1 gene promoter and Sp1 transcriptional activation through protein kinase C β1 and 8. J Biol Chem 277: 33833-33841, 2002
86. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh FN, Wu J, Brownlee M: Hyperglycemia-induced mitochondrial superoxiside overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci USA 97: 12222-12226, 2000
87. Singh LP, Crook ED: Hexosamine regulation of glucose-mediated laminine synthesis in mesangial cells involves protein kinase A and C. Am J Physiol 279: F646-F654, 2000
88. Ziyadeh FN: Evidence for the involvement of transforming growth factor-β in the pathogenesis of diabetic kidney disease: Are Koch's postulates fulfilled? Curr Pract Med. 1: 87-89, 1998
89. Sharma K, Ziyadeh FN: Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy. Semin Nephrol 17: 80-92, 1997
90. Hoffman BB, Sharma K, Zhu Y, Ziyadeh FN: Transcriptional activation of transforming growth factor-β1 in mesangial cell culture by high glucose concentration. Kidney Int 54: 1107-1116, 1998
91. Kim SJ, Glick A, Sporn MB, Roberts AB: Characterization of the promoter region of the human transforming growth factor-β1 gene. J Biol Chem 264: 402-408, 1989
92. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 93: 536-542, 1994
93. van Det NF, Verhagen NA, Tamsma JT, Berden JH, Bruijn JA, Daha MR, van der Woude FJ: Regulation of glomerular epithelial cell production of fibronectin and transforming growth factor-β by high glucose, not by angiotensin II. Diabetes 46: 834-840, 1997
94. Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN: Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule. Kidney Int 41: 107-114, 1992
95. Han DC, Isono M, Hoffman BB, Ziyadeh FN: High glucose stimulates proliferation and collagen type I synthesis in renal cortical fibroblasts: Mediation by autocrine activation of TGF-β. J Am Soc Nephrol 10: 1891-1899, 1999
96. Isono M, Mogyorósi A, Han DC, Hoffman BB, Ziyadeh FN: Stimulation of TGF-β type II receptor by high glucose in mouse mesangial cells and in diabetic kidney. Am J Physiol 278: F830-F838, 2000
97. Guh JY, Yang ML, Yang YL, Chang CC, Chuang LY: Captopril reverses high-glucose-induced growth effects on LLC-PK1 cells partly by decreasing transforming growth factor-beta receptor protein expressions. J Am Soc Nephrol 7: 1207-1215, 1996
98. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-β as a key mediator. Diabetes 44: 1139-1146, 1995
99. Sharma K, Jin Y, Guo J, Ziyadeh FN: Neutralization of TGF-13 0 by anti-TGF-β antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45: 522-530, 1996
100. Park I-S, Kiyomoto H, Abboud SL, Abboud HE: Expression of transforming growth factor-β and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46: 473-480, 1997
101. Heldin C, Miyazono K, ten Dijke P: TGF-β signaling from cell membrane to nucleus through SMAD proteins. Nature 390: 465-471, 1997
102. Massague J, Wotton D: Transcriptional control by TGF-β/Smad signaling. EMBO J. 19: 1745-1754, 2000
103. Hong SW, Isono M, Chen S, Iglesias-de la Cruz MC, Han DC, Ziyadeh FN: Increased glomerular and tubular expression of TGF-β1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am J Pathol 158: 1653-1663, 2001
104. Isono M, Chen S, Hong SW, Iglesias-de la Cruz MC, Ziyadeh FN: Smad pathway is activated in diabetic mouse kidney and Smad3 mediates TGF-β-induced fibronectin in mesangial cells. Biochem Biophys Res Comm 296: 1356-1365, 2002
105. Ziyadeh FN, Hoffman BB, Han DC, Iglesias-de la Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K: Long-term prevention of renal insufficiency, excess matrix gene expression and glomerular mesangial matrix expression by treatment with monoclonal anti-TGF-β antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97: 8015-8020, 2000
106. Chen S, Iglesias-de la Cruz MC, Jim B, Hong SW, Isono M, Ziyadeh FN: Reversibility of established diabetic nephropathy by anti-TGF-β antibody in db/db mice. Biochem Biophys Res Comm 300: 16-22, 2003
107. Yamamoto T, Nakamura T, Noble N, Ruoslahti E, Border W: Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90: 1814-1818, 1993
108. Yoshioka K, Takemura T, Murakami K, Okada M, Hino S, Miyamoto H, Maki S: Transforming growth factor-β protein and mRNA in glomeruli in normal and diseased human kidneys. Lab Invest 68: 154-163, 1993
109. Iwano M, Kubo A, Nishino T, Sato H, Nishioka H, Akai Y, Kurioka H, Fujii Y, Kanauchi M, Shiiki H, Dohi K: Quantification of glomerular TGF-β1 mRNA in patients with diabetes mellitus. Kidney Int 49: 1120-1126, 1996
110. Sharma K, Ziyadeh FN, Alzahabi B, McGowan TA, Kapoor S, Kumik BRC, Kumik PB, Weisberg LS: Increased renal production of transforming growth factor-β1 in patients with type II diabetes. Diabetes 46: 854-859, 1997
111. Sharma K, Eltayeb BO, McGowan TA, Dunn SR, Alzahabi B, Rohde R, Ziyadeh FN, Lewis EJ: Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients. Am J Kidney Dis 34: 818-823, 1999